Introduction

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Gene editing, what once sounded like the stuff of science fiction, is fast becoming a clinical reality. But there are still huge questions about access, price and ethics of this cutting-edge therapy. A Chinese scientist who sparked international controversy when he claimed he'd created the world's first Gene edited babies has been jailed for three years. So today we're asking how will gene editing change medicine? And will everyone reap the rewards?

Ian Sample speaks to Guardian science correspondent Hannah Devlin about the latest developments and debates about gene editing to emerge from a summit at the Francis Crick Institute in London. The summit heard from the first person with sickle cell disease to be treated with a technique known as Crispr. He also hears from Prof Claire Booth about ensuring these cutting edge treatments are made available to everyone who needs them. Help support our independent journalism at theguardian.com/sciencepod